153 related articles for article (PubMed ID: 35014175)
1. Comparison of the injection of low-molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis.
Belmouaz M; Goussard G; Joly F; Grand F; Sibille A; Ecotiere L; Desport E; Bauwens M; Thierry A; Bridoux F
Hemodial Int; 2022 Jul; 26(3):314-322. PubMed ID: 35014175
[TBL] [Abstract][Full Text] [Related]
2. Expanded hemodialysis: Is anticoagulation of the dialysis circuit different from online hemodiafiltration and high-flux hemodialysis?
Santos A; Macías N; Vega A; Abad S; Linares T; Aragoncillo I; Cruzado L; Pascual C; Goicoechea M; López-Gómez JM
Ther Apher Dial; 2022 Feb; 26(1):147-153. PubMed ID: 33890717
[TBL] [Abstract][Full Text] [Related]
3. Arterial line versus venous line administration of low molecular weight heparin, enoxaparin for prevention of thrombosis in the extracorporeal blood circuit of patients on haemodialysis or haemodiafiltration: A randomized cross-over trial.
Kurtkoti J; Bose B; Hiremagalur B; Sun J; Cochrane T
Nephrology (Carlton); 2016 Aug; 21(8):663-8. PubMed ID: 26609786
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G
Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration.
Santos A; Macías N; Vega A; Abad S; Linares T; Aragoncillo I; Cruzado L; Pascual C; Goicoechea M; López-Gómez JM
Clin Kidney J; 2021 Apr; 14(4):1120-1125. PubMed ID: 33841857
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of single bolus anticoagulation with enoxaparin for chronic hemodialysis. Results of an open-label post-certification study.
Klingel R; Schwarting A; Lotz J; Eckert M; Hohmann V; Hafner G
Kidney Blood Press Res; 2004; 27(4):211-7. PubMed ID: 15273423
[TBL] [Abstract][Full Text] [Related]
7. The anticoagulant activity of enoxaparin sodium during on-line hemodiafiltration and conventional hemodialysis.
Sombolos KI; Fragia TK; Gionanlis LC; Veneti PE; Bamichas GI; Fragidis SK; Georgoulis IE; Natse TA
Hemodial Int; 2009 Jan; 13(1):43-7. PubMed ID: 19210277
[TBL] [Abstract][Full Text] [Related]
8. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
9. Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins.
Belmouaz M; Goussard G; Joly F; Sibille A; Martin C; Betous T; Thierry A; Bauwens M; Bridoux F
Blood Purif; 2023; 52(3):309-318. PubMed ID: 36215951
[TBL] [Abstract][Full Text] [Related]
10. Heparin-free renal replacement therapy for chronic hemodialyzed patients at high risk for bleeding: a comparison of on-line predilution hemodiafiltration with conventional hemodialysis.
Brunot V; Serre JE; Mourad G; Klouche K; Pernin V
Hemodial Int; 2018 Oct; 22(4):463-473. PubMed ID: 29745004
[TBL] [Abstract][Full Text] [Related]
11. High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.
Maduell F; Rodas L; Broseta JJ; Gómez M; Xipell Font M; Molina A; Montagud-Marrahi E; Guillén E; Arias-Guillén M; Fontseré N; Vera Rivera M; Rico N
Artif Organs; 2019 Oct; 43(10):1014-1021. PubMed ID: 31038748
[TBL] [Abstract][Full Text] [Related]
12. Arterial Versus Venous Port Site Administration of Nadroparin for Preventing Thrombosis of Extracorporeal Blood Circuits in Patients Receiving Hemodiafiltration Treatment.
Hebibi H; Attaf D; Cornillac L; Achiche J; El Boundri F; Francais P; Chazot C; Canaud B
Kidney Int Rep; 2021 Feb; 6(2):351-356. PubMed ID: 33615060
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
14. Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.
Kim TH; Kim SH; Kim TY; Park HY; Jung KS; Lee MH; Jhee JH; Lee JE; Choi HY; Park HC
BMC Nephrol; 2019 Dec; 21(1):2. PubMed ID: 31892319
[TBL] [Abstract][Full Text] [Related]
15. Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant.
Malyszko J; Koc-Zorawska E; Kozminski P; Malyszko JS
Int Urol Nephrol; 2017 May; 49(5):875-879. PubMed ID: 28044236
[TBL] [Abstract][Full Text] [Related]
16. Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis.
Maduell F; Navarro V; Cruz MC; Torregrosa E; Garcia D; Simon V; Ferrero JA
Am J Kidney Dis; 2002 Sep; 40(3):582-9. PubMed ID: 12200811
[TBL] [Abstract][Full Text] [Related]
17. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
Lord H; Jean N; Dumont M; Kassis J; Leblanc M
Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
[TBL] [Abstract][Full Text] [Related]
18. The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins.
Kim YG; Lee SH; Jung SW; Jung GT; Lim HJ; Kim KP; Jo YI; Jin K; Moon JY
Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356029
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Hemodialysis Using a Medium Cutoff Dialyzer versus Hemodiafiltration: A Controlled Cross-Over Study.
Lindgren A; Fjellstedt E; Christensson A
Int J Nephrol Renovasc Dis; 2020; 13():273-280. PubMed ID: 33149656
[TBL] [Abstract][Full Text] [Related]
20. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.
Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F
Nephron; 2002; 92(3):589-600. PubMed ID: 12372942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
